Filing Flows

Filing Flows › Nurix Therapeutics (NRIX) › Who owns the stock

Who owns Nurix Therapeutics (NRIX) stock

202 funds reported Nurix Therapeutics (NRIX) shares in their latest 13F filings, worth $2.9B in all. The largest holder is BlackRock ($213M). Last quarter 100 funds added to their stakes and 86 cut them.

Largest holders of NRIX (13F)Largest holders of NRIX (13F)BlackRock$213MVestal Point Capital, LP$195MDeep Track Capital, LP$188MRubric Capital Management LP$175MFMR LLC$133MPrice T Rowe Associates$132MMorgan Stanley$116MState Street$113MBaker Bros. Advisors LP$113MVanguard Group$113M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock8,770,349$213Mdecrease2026-06-30
Vestal Point Capital, LP8,050,000$195Mincrease2026-06-30
Deep Track Capital, LP7,736,455$188Mincrease2026-06-30
Rubric Capital Management LP7,227,778$175Mincrease2026-06-30
FMR LLC5,485,215$133Mdecrease2026-06-30
Price T Rowe Associates5,436,587$132Mincrease2026-06-30
Morgan Stanley4,762,484$116Mdecrease2026-06-30
State Street4,677,244$113Mdecrease2026-06-30
Baker Bros. Advisors LP4,658,556$113Munchanged2026-06-30
Vanguard Group5,949,512$113Mincrease2025-12-31
Vanguard Capital Management LLC4,495,529$109Mincrease2026-06-30
Perceptive Advisors LLC4,320,422$105Mincrease2026-06-30
Redmile Group, LLC4,073,787$98.8Mdecrease2026-06-30
General Atlantic, L.P.3,032,185$73.6Mdecrease2026-06-30
Geode Capital Management, LLC2,537,291$61.6Mincrease2026-06-30

Nurix Therapeutics' latest quarter

Nurix Therapeutics, Q3 FY26: revenue $673M (85× year over year), operating margin 83.1%, net earnings $550M, operating cash flow $616M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most NRIX stock?

By the latest 13F filings: BlackRock ($213M); Vestal Point Capital, LP ($195M); Deep Track Capital, LP ($188M); Rubric Capital Management LP ($175M); FMR LLC ($133M).

What is the short interest in NRIX?

20,607,897 shares were sold short at the 2026-10-15 settlement, 16.71% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.